{"url_path":"/sec/avah/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1832332/0001193125-26-222736-index.html","accession_number":"0001193125-26-222736","cik":"0001832332","ticker":"AVAH","issuer_name":"Aveanna Healthcare Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1832332/0001193125-26-222736-index.html","primary_entity_key":"0001832332","primary_entity_name":"Aveanna Healthcare Holdings, Inc."},"word_count":70,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nDuring the quarter ended April 4, 2026, none of the directors or officers of the Company adopted, modified, or terminated any contract, instruction or written plan for the purchase or sale of the Company's securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) under the Exchange Act or any “non-Rule 10b5-1 trading arrangement”, as defined in Item 408 of Regulation S-K."}